Olga Scharkoi

Title: Olga Scharkoi: Innovator in Opioid Receptor Agonists

Introduction

Olga Scharkoi is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmacology, particularly in the development of novel opioid receptor agonists. Her work focuses on creating innovative solutions to address pain management and related medical challenges.

Latest Patents

Olga Scharkoi holds 1 patent for her invention titled "Fentanyl derivatives as pH-dependent opioid receptor agonists." This invention relates to fluorinated fentanyl derivatives that function as opioid receptor agonists. These derivatives activate target opioid receptors in a pH-dependent manner, making them selective for receptors in inflamed (acidic) environments. The patent also covers the uses of these derivatives and the pharmaceutical compositions that comprise them.

Career Highlights

Throughout her career, Olga has worked with esteemed institutions such as Charité – Universitätsmedizin Berlin and Konrad-Zuse-Institut. Her research has been pivotal in advancing the understanding of opioid receptors and their interactions with various compounds.

Collaborations

Olga has collaborated with notable colleagues, including Christian Zöllner and Christoph Stein. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Olga Scharkoi's work in developing pH-dependent opioid receptor agonists represents a significant advancement in pain management therapies. Her contributions to the field highlight the importance of innovation in addressing complex medical challenges.